176 related articles for article (PubMed ID: 30536467)
1. Semi-synthesis, antibacterial activity, and molecular docking study of novel pleuromutilin derivatives bearing cinnamic acids moieties.
Deng Y; Tang D; Wang QR; Huang S; Fu LZ; Li CH
Arch Pharm (Weinheim); 2019 Jan; 352(1):e1800266. PubMed ID: 30536467
[TBL] [Abstract][Full Text] [Related]
2. Synthesis and Antibacterial Activity Against MRSA of Pleuromutilin Derivatives Possessing a Mercaptoethylamine Linker.
Zhang ZS; Huang YZ; Luo J; Wang BF; Jin Z; Liu YH; Tang YZ
Med Chem; 2018; 14(6):585-594. PubMed ID: 29663895
[TBL] [Abstract][Full Text] [Related]
3. Design, synthesis, and antibacterial activity of novel pleuromutilin derivatives bearing an amino thiazolyl ring.
Ling Y; Wang X; Wang H; Yu J; Tang J; Wang D; Chen G; Huang J; Li Y; Zheng H
Arch Pharm (Weinheim); 2012 Aug; 345(8):638-46. PubMed ID: 22532317
[TBL] [Abstract][Full Text] [Related]
4. Design, synthesis, in vitro and in vivo evaluation against MRSA and molecular docking studies of novel pleuromutilin derivatives bearing 1, 3, 4-oxadiazole linker.
Liu J; Zhang GY; Zhang Z; Li B; Chai F; Wang Q; Zhou ZD; Xu LL; Wang SK; Jin Z; Tang YZ
Bioorg Chem; 2021 Jul; 112():104956. PubMed ID: 33991838
[TBL] [Abstract][Full Text] [Related]
5. Design, synthesis, in vitro and in vivo evaluation and molecular docking study of novel pleuromutilin derivatives as antibacterial agents.
Liu J; Ren J; Zuo XY; Zhou KX; Tang YZ; Jin Z
Fitoterapia; 2024 Jul; 176():106046. PubMed ID: 38821322
[TBL] [Abstract][Full Text] [Related]
6. Design, synthesis, and structure-activity relationship studies of novel pleuromutilin derivatives having a piperazine ring.
Luo J; Yang QE; Yang YY; Tang YZ; Liu YH
Chem Biol Drug Des; 2016 Nov; 88(5):699-709. PubMed ID: 27273921
[TBL] [Abstract][Full Text] [Related]
7. Design, synthesis and antibacterial evaluation of novel pleuromutilin derivatives possessing piperazine linker.
Gao ML; Zeng J; Fang X; Luo J; Jin Z; Liu YH; Tang YZ
Eur J Med Chem; 2017 Feb; 127():286-295. PubMed ID: 28068600
[TBL] [Abstract][Full Text] [Related]
8. Synthesis and Biological Activity Evaluation of Novel Heterocyclic Pleuromutilin Derivatives.
Yi Y; Fu Y; Dong P; Qin W; Liu Y; Liang J; Shang R
Molecules; 2017 Jun; 22(6):. PubMed ID: 28617344
[TBL] [Abstract][Full Text] [Related]
9. Discovery of novel pleuromutilin derivatives as potent antibacterial agents.
Zhou Y; Yi Y; Wang J; Yang Z; Liu Q; Pu W; Shang R
Eur J Med Chem; 2022 Jul; 237():114403. PubMed ID: 35472849
[TBL] [Abstract][Full Text] [Related]
10. Synthesis, biological activities and docking studies of pleuromutilin derivatives with piperazinyl urea linkage.
Zhang Y; Xie C; Liu Y; Shang F; Shao R; Yu J; Wu C; Yao X; Liu D; Wang Z
J Enzyme Inhib Med Chem; 2021 Dec; 36(1):764-775. PubMed ID: 33733986
[TBL] [Abstract][Full Text] [Related]
11. A click chemistry approach to pleuromutilin derivatives, evaluation of anti-MRSA activity and elucidation of binding mode by surface plasmon resonance and molecular docking.
Zhang Z; Zhang ZS; Wang X; Xi GL; Jin Z; Tang YZ
J Enzyme Inhib Med Chem; 2021 Dec; 36(1):2087-2103. PubMed ID: 34823417
[TBL] [Abstract][Full Text] [Related]
12. Synthesis and antibacterial activities of novel pleuromutilin derivatives bearing an aminothiophenol moiety.
Zhang ZS; Huang YZ; Luo J; Jin Z; Liu YH; Tang YZ
Chem Biol Drug Des; 2018 Sep; 92(3):1627-1637. PubMed ID: 29722184
[TBL] [Abstract][Full Text] [Related]
13. Novel pleuromutilin derivatives as antibacterial agents: synthesis, biological evaluation and molecular docking studies.
Wang X; Ling Y; Wang H; Yu J; Tang J; Zheng H; Zhao X; Wang D; Chen G; Qiu W; Tao J
Bioorg Med Chem Lett; 2012 Oct; 22(19):6166-72. PubMed ID: 22932314
[TBL] [Abstract][Full Text] [Related]
14. Novel pleuromutilin derivatives with excellent antibacterial activity against Staphylococcus aureus.
Xu P; Zhang YY; Sun YX; Liu JH; Yang B; Wang YZ; Wang YL
Chem Biol Drug Des; 2009 Jun; 73(6):655-60. PubMed ID: 19635057
[TBL] [Abstract][Full Text] [Related]
15. Synthesis, biological activities, and docking study of novel chalcone-pleuromutilin derivatives.
Xie C; Zhang S; Zhang W; Wu C; Yong C; Sun Y; Zeng Z; Zhang Q; Huang Z; Chen T; Zhang Y
Chem Biol Drug Des; 2020 Aug; 96(2):836-849. PubMed ID: 32271987
[TBL] [Abstract][Full Text] [Related]
16. Synthesis and Pharmacological Evaluation of Novel Pleuromutilin Derivatives with Substituted Benzimidazole Moieties.
Ai X; Pu X; Yi Y; Liu Y; Xu S; Liang J; Shang R
Molecules; 2016 Nov; 21(11):. PubMed ID: 27834819
[TBL] [Abstract][Full Text] [Related]
17. Cyclopentanone ring-cleaved pleuromutilin derivatives.
Springer DM; Bunker A; Luh BY; Sorenson ME; Goodrich JT; Bronson JJ; DenBleyker K; Dougherty TJ; Fung-Tomc J
Eur J Med Chem; 2007 Jan; 42(1):109-13. PubMed ID: 17156897
[TBL] [Abstract][Full Text] [Related]
18. Design, synthesis and biological evaluation of novel pleuromutilin derivatives possessing 4-aminothiophenol linker as promising antibacterial agents.
Chai F; Wang J; Zhou KX; Wang SK; Liu YH; Jin Z; Tang YZ
Bioorg Chem; 2022 Sep; 126():105859. PubMed ID: 35605553
[TBL] [Abstract][Full Text] [Related]
19. Synthesis and antibacterial activities of novel pleuromutilin derivatives.
Yi Y; Fu Y; Wang K; Shui Y; Cai J; Jia Z; Niu B; Liang J; Shang R
Arch Pharm (Weinheim); 2018 Sep; 351(9):e1800155. PubMed ID: 30058185
[TBL] [Abstract][Full Text] [Related]
20. Synthesis and evaluation of novel pleuromutilin derivatives with a substituted pyrimidine moiety.
Yi Y; Yang G; Zhang C; Chen J; Liang J; Shang R
Eur J Med Chem; 2015 Aug; 101():179-84. PubMed ID: 26134552
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
